Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation

BioFactors

Volumn 40, Issue 5, 2014, Pages 482-493

  Stefani, Massimo ^a   Rigacci, Stefania ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Amyloid aggregation; Mediterranean diet; Natural polyphenols; Nutraceuticals

Indexed keywords

ANIMALIA;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; PLANT MEDICINAL PRODUCT; POLYPHENOL;

AMYLOIDOSIS; ANIMAL; AUTOPHAGY; HUMAN; MEDITERRANEAN DIET; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

AMYLOIDOSIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AUTOPHAGY; DIET, MEDITERRANEAN; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PLANT PREPARATIONS; POLYPHENOLS;

EID: 84907998488     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1171     Document Type: Review

References (126)

1. Stefani, M. and Dobson, C. M. (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81, 678-699.
2. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366.
3. Gama Sosa, M. A., De Gasperi, R., and Elder, G. A. (2012) Modeling human neurodegenerative diseases in transgenic systems. Hum. Genet. 131, 535-563.
4. Selkoe, D. J. (2003) Folding proteins in fatal ways. Nature 426, 900-904.
5. Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., et al. (2010) Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17, 101-104.
6. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., et al. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92, 1989-1993.
7. Lambert, M. P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., et al. (1998) Diffusible nonfibrillar ligands derived from Aβ are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 93, 6448-6453.
8. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., et al. (1999) Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945-25952.
9. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., et al. (2002) Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
10. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., et al. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84.
11. Gong, Y., Chang, I., Viola, K. I., Lacor, P. N., Lambert, M. P., et al. (2003) Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA 100, 10417-10422.
12. Lesné, S., Koh, M. T., Kotlinek, L., Kayed, R., Glabe, C. G., et al. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357.
13. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., and LaFerla, F. (2005) Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
14. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., et al. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
15. Caldeira, G. L., Ferreira, I. L., and Rego, A. C. (2013) Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. J. Alzheimers Dis. 34, 115-131.
16. Sciacca, M. F., Milardi, D., Messina, G. M., Marletta, G., Brender, J. R., et al. (2013) Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. Biophys. J. 104, 173-184.
17. Kourie, J. I. (2001) Mechanisms of amyloid β protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell. Mol. Neurobiol. 21, 173-213.
18. Balietti, M., Giorgetti, B., Casoli, T., Solazzi, M., Tamagnini, F., et al. (2013) Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease. J. Alzheimers Dis. 34, 887-896.
19. Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2030-2041.
20. Roussel, B. D., Kruppa, A. J., Miranda, E., Crowther, D. C., Lomas, D. A., et al. (2013) Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 12, 105-118.
21. Ross, C. A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819-822.
22. Sochocka, M., Koutsouraki, E. S., Gasiorowski, K., Leszek, J. (2013) Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: new approach to therapy. CNS Neurol. Disord. Drug Targets. 12, 870-881.
23. Bucciantini, M., Rigacci, S., Berti, A., Pieri, L., Cecchi, C., et al. (2005) Patterns of cell death triggered in two different cell lines by HypF-N pre-fibrillar aggregates FASEB J. 19, 437-439.
24. Velez-Pardo, C., Arroyave, S. T., Lopera, F., Castano, A. D., and Jimenez Del Rio, M. (2001) Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation. J. Alzheimers Dis. 3, 409-415.
25. Eikelemboom, R., Bate, C., Van Gool, W. A., Hoozemans, J. J., Rozemuller, J. M., et al. (2002) Neuroinflammation in Alzheimer's disease and prion disease. Glia 40, 232-239.
26. Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., et al. (2010) Microglial Cx3cr1 knockout in a mouse model of Alzheimer's disease. Nat. Neurosci. 13, 411-413.
27. Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., et al. (2002) Targeted pharmaceutical depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254-259.
28. Yang, S.G., Wang, W.Y., Ling, T.J., Feng, Y., Du, X.T., et al. (2010) α-Tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines. Neurochem. Int. 57, 914-922.
29. Choi, D. Y., Lee, Y. J., Hong, J. T., and Lee, H. J. (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res. Bull. 87, 144-153.
30. Rogers, I., Kerr, F., Martinez, P., Hardy, J., Lovestone, S., et al. (2012) Ageing increases vulnerability to Aβ42 toxicity in Drosophila. PLoS One. 7, e40569.
31. Keller, J. N., Huang, F. F., and Markesbery, W. R. (2002) Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98, 149-156.
32. Fratta, P., Engel, W. K., McFerrin, J., Davies, K. J., Lin, S. W., et al. (2005) Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am. J. Pathol. 167, 517-526.
33. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., et al. (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 112, 24-49.
34. Mattson, M. P. (1999) Impairment of membrane transport and signal transduction systems by amyloidogenic proteins. Methods Enzymol. 309, 733-768.
35. Du, H. and Yan, S. S. (2010) Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta. Biochim. Biophys. Acta. 1802, 198-204.
36. Squier, T. C. (2001) Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 36, 1539-1550.
37. Kawahara, M., Kuroda, Y., Arispe, N., and Rojas, E. (2000) Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevation by a common mechanism in a hypopthalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083.
38. Hou, X., Parkington, H. C., Coleman, H. A., Mechler, A., Martin, L. L., et al. (2007) Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J. Neurochem. 100, 446-457.
39. 2+ increase in primary neuronal cells. J. Biol. Chem. 283, 29950-29960.
40. Tangney, C. C., Kwasny, M. J., Li, H., Wilson, R. S., Evans, D. A., et al. (2011) Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am. J. Clin. Nutr. 93, 601-607.
41. Ladiwala, A. R., Dordick, J. S., and Tessier, P. M. (2011) Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J. Biol. Chem. 286, 3209-3218.
42. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol.15, 558-566.
43. Stefani, M. and Rigacci, S. (2013) Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int. J. Mol. Sci. 14, 12411-12457.
44. Caesar, I., Jonson, M., Nilsson, K.P.R., Thor, S., and Hammarström, P. (2012) Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS One 7, e31424.
45. Wang, S. S. -S., Liu, K. -N., and Lee, W. -H. (2009) Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme. Biophys. Chem. 144, 78-87.
46. Daval, M., Bedrood, S., Gurlo, T., Huang, C. J., Costes, S., et al. (2010) The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 17, 118-128.
47. Bratkovič, I. H., Gašperšič, J., Šmid, L. M., Bresjanac, M., and Jerala, R. (2008) Curcumin binds to the α-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrPSc accumulation. J. Neurochem. 104, 1553-1564.
48. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., et al. (2010) EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA 107, 7710-7715.
49. Miyata, M., Sato, T., Kugimiya, M., Sho, M., Nakamura, T., et al. (2010) The crystal Structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the Thyroxine binding site. Biochemistry 49, 6104-6114.
50. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., et al. (2000) Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 7, 312-321.
51. Rigacci, S., Guidotti, V., Bucciantini, M., Parri, M., Nediani, C., et al. (2010) Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J. Nutr. Biochem. 21, 726-735.
52. Rigacci, S., Guidotti, V., Bucciantini, M., Nichino, D., Relini, A., et al. (2011) Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr. Alzheimer Res. 8, 841-852.
53. Wang, Y.J., Thomas, P., Zhong, J. H., Bi, F. F., Kosaraju, S., et al. (2009) Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox Res. 15, 3-14.
54. Ferreira, N., Saraiva, M. J., and Almeida, M. R. (2011) Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 585, 2424-2430.
55. Ferreira, N., Santos, S. A. O., Domingues, M. R. M., Saraiva, M. J., Almeida, M. R. (2013) Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition. Biochim. Biophys. Acta 1832, 39-45.
56. Diomede, L., Rigacci, S., Romeo, M., Stefani, M., and Salmona, M. (2013) Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit. PLoS One 8, e58893.
57. Grossi, C., Rigacci, S., Ambrosini, S., Ed Dami, T., Luccarini, I., et al. (2013) The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLOS One 8, e71702.
58. Bachmanov, A. A., Reed, D. R., Beauchamp, G. K., and Tordoff, M. G. (2002). Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet. 32, 435-443.
59. Servili, M., Esposto, S., Fabiani, R., Urbani, S., Taticchi, A., et al. (2009) Phenolic compounds in olive oil: antioxidant, health and organoleptic activities according to their chemical structure. Inflammopharmacology 17, 76-84.
60. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324.
61. Hamaguchi, T., Ono, K., Murase, A., and Yamada, M. (2009) Phenolic compounds prevent Alzheimer's pathology through different effects on the Amyloid-β aggregation pathway. Am. J. Pathology 175, 2557-2565.
62. Jagota, S., and Rajadas, J. (2012) Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans. Neurochem. Res. 37, 40-48.
63. Kim, H., Park, B. -S., Lee, K. -G., Choi, C. Y., Jang, S. S., et al. (2005) Effects of naturally occurring compounds on fibril formation and oxidative stress of β-Amyloid. J. Agric. Food Chem. 53, 8537-8541.
64. Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., et al. (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25, 8807-8814.
65. Kostomoiri, M., Fragkouli, A., Sagnou, M., Skaltsounis, L. A., Pelecanou, M., et al. (2013) Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the Amyloid Precursor Protein (AβPP). Cell. Mol. Neurobiol. 33, 147-154.
66. Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., and Sugimoto, H. (2008) Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta 1780, 819-825.
67. Wang, P., Su, C., Li, R., Wang, H., Ren, Y., et al. (2014) Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. J Neurosci. Res. 92, 218-231.
68. Lewandowska, U., Szewczyk, K., Hrabec, E., Janecka, A., and Gorlach, S. (2013) Overview of metabolism and bioavailability enhancement of polyphenols. J. Agric. Food Chem. 61, 12183-12199.
69. Khymenets, O., Fitó, M., Touriño, S., Muñoz-Aguayo, D., Pujadas, M., et al. (2010) Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion. Drug Metab. Dispos. 38, 1417-1421.
70. Kanner, J., Gorelik, S., Roman, S., and Kohen, R. (2012) Protection by polyphenols of postprandial human plasma and low-density lipoprotein modification: the stomach as a bioreactor. J. Agric. Food Chem. 60, 8790-8796.
71. Sarsour, E. H., Kumar, M. G., Kalen, A. L., Goswami, M., Buettner, G. R., et al. (2012) MnSOD activity regulates hydroxytyrosol-induced extension of chronological lifespan. Age (Dordr) 34, 95-109.
72. Sarbishegi, M., Mehraein, F., and Soleimani M. (2014) Antioxidant tole of oleuropein on midbrain and dopaminergic neurons of substantia nigra in aged rats. Iranian Biomed. J. 18, 16-22.
73. Na, H. K. and Surh, Y. J. (2008) Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem. Toxicol. 46, 1271-1278.
74. Elbling, L., Weiss, R. M., Teufelhofer, O., Uhl, M., Knasmueller, S., et al. (2005) Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 19, 807-809.
75. Nakagawa, H., Hasumi, K., Woo, J.T., Nagai, K., and Wachi, M. (2004) Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 25, 1567-1574.
76. Borchi, E., Bargelli, V., Guidotti, V., Berti, A., Stefani, M., et al. (2014) Mild exposure of RIN-5F β-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: an hormetic stimulus. Redox Biol. 2, 114-122.
77. Son, J. H., Shim, J. H., Kim, K. -H., Ha, J. -Y., and Han, J. Y. (2012) Neuronal autophagy and neurodegenerative diseases. Exp. Mol. Med. 44, 89-98.
78. Ling, D., Magallanes, M., and Salvaterra, P. M. (2014) Accumulation of amyloid-like Aβ1-42 in autophagy-endosomal-lysosomal (AEL) vesicles: potential implications for plaque biogenesis. ASN Neuro. 6, e00139.
79. Pickford, F., Masliah, E., Britschg, I. M., Lucin, K., Narasimhan, R., et al. (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190-2199.
80. Lee, J. H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., et al. (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146-1158.
81. Shibata, M., Lu, T., Furuya, T., Degterev, A., Mizushima, N., et al. (2006) Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 281, 14474-14485.
82. Bové, J., Martínez-Vicente, M., and Vila, M. (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat. Rev. Neurosci. 12, 437-452.
83. Morselli, E., Maiuri, M.C., Markaki, M., Megalou, E., Pasparaki, A., et al. (2010) Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 1:e10.
84. Chen, M.L., Yi, L., Jin, X., Liang, X.Y., Zhou, Y., et al. (2013) Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy 9, 2033-2045.
85. Wang, M., Yu, T., Zhu, C., Sun, H., Qiu, Y., et al. (2014) Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutr Cancer. 66, 435-40.
86. Kim, H. S., Montana, V., Jang, H. J., Parpura, V., and Kim, J. A. (2013) Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. J. Biol. Chem. 288, 22693-22705.
87. Xiao, K., Jiang, J., Guan, C., Dong, C., Wang, G., et al. (2013) Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J. Pharmacol. Sci. 123, 102-109.
88. Filomeni, G., Desideri, E., Cardaci, S., Graziani, I., Piccirillo, S., et al. (2010) Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 6, 202-216.
89. Menendez, J. A., Joven, J., Aragonès, G., Barrajón-Catalán, E., Beltrán-Debón, R., et al. (2013) Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle 12, 555-578.
90. Pallauf, K. and Rimbach, G. (2013) Autophagy, polyphenols and healthy ageing. Ageing Res. Rev. 12, 237-252.
91. Mariño, G., Niso-Santano, M., Baehrecke, E. H., and Kroemer, G. (2014) Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 15, 81-94.
92. Chu, A. J. (2014) Antagonism by bioactive polyphenols against inflammation: a systematic view. Inflamm. Allergy Drug Targets. 13, 34-64.
93. Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P., and Ma, D. (2014) Neuroinflammation: the role and consequences. Neurosci. Res. 79, 1-12.
94. Xu, P. X., Wang, S. W., Yu, X. L., Su, Y. J., Wang, T., et al. (2014) Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Behav. Brain Res. 264, 173-180.
95. Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., et al. (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther. 326, 196-208.
96. Manach, C., Williamson, G., Morand, C., Scalbert, A., and Rémésy, C. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81, 230S-242S.
97. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomark. Prev. 11, 1025-1032.
98. Chen, Z., Zheng, S., Li, L., and Jiang, H. (2014) Metabolism of flavonoids in human: a comprehensive review. Curr. Drug. Metab. 15, 48-61.
99. Hamaguchi, T., Ono, K., and Yamada, M. (2010) Curcumin and Alzheimer's disease. CNS Neurosci. Ther. 16, 285-297.
100. Serra, A., Rubio, L., Borras, X., Macia, A., Romero, M. P., et al. (2012) Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol. Nutr. Food Res. 3, 486-496.
101. Mereles, D. and Hunstein, W. (2011) Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int. J. Mol. Sci. 12, 5592-5603.
102. Markopoulos, C., Vertzoni, M., Agalis, A., Magiatis, P., and Reppas, C. (2009) Stability of oleuropein in the human proximal gut. J. Pharm. Pharmacol. 61, 143-149.
103. Mourtzinos, I., Salta, F., Yannakopoulou, K., Chiou, A., and Karathanos, V.T. (2007) Encapsulation of olive leaf extract in beta-cyclodextrin. J. Agric. Food Chem. 55, 8088-8094.
104. Cheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H., et al. (2013) Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice. AAPS J. 15, 324-336.
105. Kim, T. H., Jiang, H. H., Youn, Y. S., Park, C. W., Tak, K. K., et al. (2011) Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int. J. Pharm. 403, 285-291.
106. Rocha, S., Generalov, R., Pereira Mdo, C., Peres, I., Juzenas, P., et al. (2011) Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine (Lond.) 6, 79-87.
107. Mignet, N., Seguin, J., and Chabot, G. G. (2013) Bioavailability of polyphenol liposomes: a challenge ahead. Pharmaceutics 5, 457-471.
108. Baum, L., Lam, C. W., Cheung, S. K., Kwok, T., Lui, V., et al. (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28, 110-113.
109. Ringman, J. M., Cole, G. M., Tend, E., Badmaev, V., Bardens, J., et al. (2008) Oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study. In: Proceedings of the Abstract of International Conference on Alzheimer's Disease, Chicago, USA, pp. T774.
110. DiSilvestro, R. A., Joseph, E., Zhao, S., and Bomser, J. (2012) Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr. J. 26, 11:79.
111. Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., et al. (2012) Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 4, 43.
112. Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., et al. (2011) Clinical trials of resveratrol. Ann. NY. Acad. Sci. 1215, 161-169.
113. Goldberg, D. M., Yan, J., and Soleas, G. J. (2003). Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36, 79-87.
114. Kristen, A. V., Lehrke, S., Buss, S., Mereles, D., Steen, H., et al. (2012) Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clin. Res. Cardiol. 101, 805-813.
115. Howes, M.J. and Perry, E. (2011) The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 28, 439-468.
116. Oskouei, D.S., Rikhtegar, R., Hashemilar, M., Sadeghi-Bazargani, H., Sharifi-Bonab, M., et al. (2013) The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial. J. Stroke Cerebrovasc. Dis. 22, e557-563.
117. Rainer, M., Mucke, H., and Schlaefke, S. (2013) Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting. Wien Klin. Wochenschr. 125, 8-15.
118. Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., et al. (2012) Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J. Psychiatr. Res. 46, 716-723.
119. Bachinskaya, N., Hoerr, R., and Ihl, R. (2011) Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatr. Dis. Treat. 7, 209-215.
120. Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., et al. (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 11, 851-859.
121. Berr, C., Portet, F., Carriere, I., Akbaraly, T.N., Feart, C., et al. (2009) Olive oil and cognition: results from the three-city study. Dement. Geriatr. Cogn. Disord. 28, 357-364.
122. Valls-Pedret, C., Lamuela-Raventós, R. M., Medina-Remón, A., Quintana, M., Corella, D., et al. (2012) Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J. Alzheimers Dis. 29, 773-782.
123. Martínez-Lapiscina, E. H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvadó, R., et al. (2013) Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J. Neurol. Neurosurg. Psychiatry. 84, 1318-1325.
124. Féart, C., Samieri, C., Allès, B., and Barberger-Gateau, P. (2013) Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc. Nutr. Soc. 72, 140-152.
125. Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B., and Ascherio, A. (2012) Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology 78, 1138-1145.
126. Reznichenko, L., Amit, T., Zheng, H., Avramovich-Tirosh, Y., Youdim, M. B., et al. (2006) Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J. Neurochem. 97, 527-536.